Colgate-Palmolive (NYSE:CL) Shares Acquired by Strategic Blueprint LLC

Strategic Blueprint LLC increased its stake in Colgate-Palmolive (NYSE:CL) by 88.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,762 shares of the company’s stock after acquiring an additional 5,993 shares during the period. Strategic Blueprint LLC’s holdings in Colgate-Palmolive were worth $1,160,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Union Bancaire Privee UBP SA purchased a new position in shares of Colgate-Palmolive during the fourth quarter worth about $32,000. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the third quarter worth about $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the third quarter worth about $53,000. Prospera Private Wealth LLC purchased a new position in shares of Colgate-Palmolive during the third quarter worth about $64,000. Finally, True Wealth Design LLC grew its holdings in shares of Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after purchasing an additional 672 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 0.2 %

CL opened at $89.65 on Thursday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a market cap of $73.24 billion, a P/E ratio of 25.69, a PEG ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The business’s fifty day simple moving average is $91.67 and its 200 day simple moving average is $97.34.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Stifel Nicolaus dropped their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. Finally, Barclays cut their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $102.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.